EGFR expression was significantly more frequent in castration-resistant bone metastases, when compared to its distribution in primary tumours (n = 39 vs. n = 1841, Chi2 = 11.543, p = 0.009, Fig. 4c, d). The gene discussed is EGFR; the disease is neoplasm.